Concepedia
Author
Patrick Schöffski
Also Known As
P SCHOFFSKI, P Schoffski, P Schöffski, P Schöffski, P. Schoffski, P. Schöffski, P., Schöffski, Patrick Schoffski, Patrick Schöffski, Patrick Schöffski
1.1K
Publications
43.1K
Citations
92
H-Index
178
Concepts
All Affiliations
1
60
174
19.4K
2
21
32
3.6K
3
5
614
4
165
×
All Concepts
335
40K
88
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González, +28
New England Journal of Medicine
2019
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
Winette T.A. van der Graaf, Jean‐Yves Blay, Sant P. Chawla, +20
The Lancet
Metastatic Soft-tissue SarcomaPlacebo-controlled Phase 3MedicineMetronomic TherapyClinical Trials +6
2012
2K
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paolo G. Casali, N. Abecassis, Sebastian Bauer, +58
Annals of Oncology
2018
1.6K
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
George D. Demetri, Peter Reichardt, Yoon‐Koo Kang, +21
Gastrointestinal OncologyMedicinePharmacologyPathologyPharmacotherapy +4
1.4K
Cabozantinib in Progressive Medullary Thyroid Cancer
Rossella Elisei, Martin Schlumberger, Stefan Müller, +15
Journal of Clinical Oncology
2013
1.2K
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
Ian Judson, Jaap Verweij, Hans Gelderblom, +16
The Lancet Oncology
Metastatic Soft-tissue SarcomaVersus Intensified DoxorubicinOncologyMalignant DiseasePathology +5
2014
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Alessandro Gronchi, Aisha Miah, Angelo Paolo Dei Tos, +74
Surgical OncologySoft Tissue SurgeryVisceral SarcomasSurgical PathologyHistopathology +4
2021
879
Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer
Eric Van Cutsem, Helgi van de Velde, Petr Karásek, +11
2004
772
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
Patrick Schöffski, Sant P. Chawla, Robert G. Maki, +15
OncologyMetronomic TherapyPharmacologyAdvanced LiposarcomaEribulin Versus Dacarbazine +4
2016
753
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paolo G. Casali, N. Abecassis, Sebastian Bauer, +57
747
Page 1